Coherent's (US) urology laser approved in Japan:
This article was originally published in Clinica
The Japanese Ministry of Health and Welfare has granted approval to Coherent (US) for use of the VersaPulse holmium laser to destroy urinary stones. The company says it is the first approval for this procedure in Japan using a solid-state laser. The product application was filed in May 1993 using data from clinical trials conducted at Kurume University Medical School and Nara Medical University. Japan is Coherent's largest potential market for holmium laser lithotripsy, according to Peter Falzon, manager of Coherent Japan. It is the world leader in high technology urinary stone management with over 500 extracorporeal shockwave lithotripter installations.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.